NCT02654977View on ClinicalTrials.gov

CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 29, 2015

Primary Completion Date

November 14, 2019

Study Completion Date

November 14, 2019

Conditions

Familial Partial LipodystrophyNonalcoholic SteatohepatitisNAFLD

Interventions

DRUG

Metreleptin

MyaLept (Recombinant-methionyl Human Leptin (r-metHuLeptin) METRELEPTIN) subcutaneous injections

Trial Locations (1)

48105

University of Michigan, Ann Arbor

All Listed Sponsors

lead

University of Michigan

OTHER

NCT02654977 - CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy | Biotech Hunter | Biotech Hunter